Evidence map›Paper›PMID 42200179›Full record

ArticleFrontiers in physiology2026

Live high, train smart: translating altitude physiology to best practice with mechanistic insights.

Raphaël Faiss, Olivier Girard

Abstract read
In one paragraph

Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Raphaël FaissInstitute of Sports Sciences, University of Lausanne, Lausanne, Switzerland.
Olivier GirardSchool of Human Sciences, University of Western Australia, Perth, WA, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first symposium on altitude training took place 60 years ago in Magglingen (Switzerland), where preparation for the 1968 Mexico Olympic Games provided "an excellent opportunity for the study of human adaptability" in hypoxic environments. Decades later, altitude or hypoxic training blocks -discrete periods (typically days to weeks) during which athletes reside, train, or intermittently expose themselves to hypoxia to stimulate physiological adaptations-have become a common component of elite endurance and team-sport training. Traditional strategies such as "live high-train high" and "live high-train low" have largely been adopted to stimulate erythropoiesis. The principal performance target is an increase in total hemoglobin mass (tHbmass), thereby enhancing O2 delivery to the working muscles through a higher arterial oxygen content. Despite ongoing debate regarding the precise physiological mechanisms underpinning altitude training adaptations, many key lessons were learned in the past 25 years related to hypoxic dose, exposure timing, and inter-individual variability in adaptative responses. Reflecting sustained scientific interest, no less than 12 comprehensive reviews or meta-analyses on altitude training strategies have been published in the past five years alone. These studies consistently report erythropoietic adaptations to hypoxia while seeking to refine practical recommendations regarding the optimal altitude severity and duration of exposure to potentiate increases in tHbmass. In this perspective article, potential vectors of performance improvement associated with hypoxic/altitude training were reconceptualized. By mapping contemporary altitude training strategies alongside their respective physiological mechanisms, we propose a framework that may help guide evidence-informed practice for research end-users seeking to boost their performance.

Indexed as

altitudeathleteshypoxiaperformancetraining

Identifiers

PMID42200179
PMCPMC13199005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.